Brief: Aileron Therapeutics Says Board Appointed Manuel Aivado, Co's CEO To Serve As Co's Principal Financial Officer, Principal Accounting Officer

Rein Therapeutics

07/06/2022 13:43

June 7 (Reuters) - Aileron Therapeutics Inc  ALRN.O :
    * AILERON THERAPEUTICS - ON JUNE 5, BOARD APPOINTED MANUEL
AIVADO,
CO’S CEO TO SERVE AS CO’S PRINCIPAL FINANCIAL OFFICER, PRINCIPAL
ACCOUNTING OFFICER
    * AILERON THERAPEUTICS - ON JUNE 5, BOARD APPOINTS MANUEL
AIVADO,
CO'S CEO TO SERVE AS CO'S PRINCIPAL FINANCIAL OFFICER AND
PRINCIPAL ACCOUNTING OFFICER

Further company coverage:  ALRN.O 

 ((reuters.briefs@thomsonreuters.com;))